Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 13 of 13 for “"big pharma"”.
-
'Pyrates' of the Lyceum: Big Pharma, Patents, and Academic Freedom in Neoliberal Times
… this brave new world and the intellectual pyscho-pharmacology and ideology of neoliberalism.
-
Development of KPIs for an Innovation Initiative between Big Pharma and SMEs. A case study of AstraZeneca’s BioVentureHub
… treatments. The life science industry faces two big challenges when trying to create innovative treatments; the difficulty in finding funding, infrastructure and laboratories for small and medium-sized enterprises, and the struggle in constantly innovating and bringing NewMolecular Entities to …
-
Innovation in pharma companies: an investigation of R&D and external knowledge acquisition
… by the rise of biotechnology and big pharma's increasing reliance on internal and external R&D, the first aim of this study is to obtain an in-depth understanding of the distinctive effects the different knowledge acquisition strategies, R&D and collaborations, have on big pharma's …
-
Essays on Industrial Organization
Big pharma is increasingly using acquisitions to fill their R&D pipelines and the proliferation of the biotechnology industry has created a thick market of innovative target startups. This dissertation analyzes the dynamic equilibrium effects of biotech startup acquisitions by big pharma on drug …
-
Risk society and the fight for kratom use
… sector of the economy and the dominance of Big Pharma, has the consequences of proliferating the use of non-sanctioned forms of health care. The Southeast Asian plant Kratom is one such illustration of this phenomenon. Drawing from over 200 Reddit posts on r/Kratom, this research analyzes …
-
An Idealized Design For A Networked Change Approach In A Pharmaceutical R&D Organization
Big Pharma is confronted with an unsustainable business model. This is characterized by high attrition rates for medicines under development, increasing regulatory thresholds, and technical complexity of treating diseases of unmet medical need (e.g. Alzheimer’s ). This has driven up the cost of …
-
Problems Facing the Pharmaceutical Industry and Approaches to Ensure Long Term Viability
This paper examines the Pharmaceutical (Pharma) industry and the changes that have occurred particularly over the last 10 years as a result of the overall economic downturn, the rising cost of healthcare and the costs associated with the development and sales of pharmaceuticals. One response of big …
-
Psycho-colonialism: colonisation in mental health
… disciplines alongside business interests like ‘Big Pharma’. I argue that psychiatric practices are also colonising processes in the Global North: what I call psycho-colonisation. This thesis begins by outlining a rationale for interdisciplinary engagement with psycho-colonisation which includes …
-
As políticas públicas de resistência em saúde humana na dinâmica capitalista do setor fármaco: um estudo empírico da Fiocruz e de seu Instituto Tecnológico em Fármacos / Far Manguinhos na era das parcerias
… anti-retrovirais, de titularidade das Big Pharma e de outro, o direito universal de acesso à saúde das populações dos países mais pobres do planeta, tendo o Brasil como o grande protagonista na defesa dos direitos humanos globais. Segundo Mahoney e Morel (2006), as tensões oriundas do …
-
Beyond the Legalization of Marijuana: Economics of Marijuana as a Drug and Herbal Supplement
… they have not critically analyzed how the pharmaceutical industry might react when synthetic cannabinoid compounds could be incorporated into new products. I argue that when marijuana is federally legal, there will be two independent market developments in: i) the cannabis market, which …
-
An Experimental Investigation into the Impact of Crisis Response Strategies and Relationship Management in the Pharmaceutical Industry
… how millennials view their relationship with the pharmaceutical industry and if that relationship changes when exposed to different crisis messaging strategies. The pharmaceutical industry is currently dealing with a preventable crisis because of companies in the industry, such as opioid …
-
Versterking van de WHO: Balanceren tussen slagkracht en rechtsstatelijke waarborgen
… macht in de vorm van geldschieters, zoals ‘big pharma’, die het beleid beïnvloeden. Ondanks pogingen van de WHO dit te verbeteren, blijft het een aandachtspunt. Verdragsbepalingen waarmee een nieuw besluitvormend orgaan waarvan mogelijk ook private partijen (weliswaar zonder stemrecht) deel …